Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-19

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals of New York LLC's original application for dexmethylphenidate hydrochloride as a generic treatment for attention-deficit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)